Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
NCT05749653
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
6500
Enrollment
OTHER
Sponsor class
Conditions
Onchocerciasis
Epilepsy
Interventions
DRUG:
Bi-annual CDTI
Sponsor
Universiteit Antwerpen